ConductScience.org, home

Paper6213633

Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.

Harris AL and 5 others. J Clin Endocrinol Metab, 1982. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer. Papers, record 6213633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6213633

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
3.84
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harris ALA L
2Dowsett MM
3Jeffcoate SLS L
4McKinna JAJ A
5Morgan MM
6Smith IEI E

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglutethimideMajor topic
Breast NeoplasmsMajor topic
Adult
Androstenedione
Dehydroepiandrosterone
Dehydroepiandrosterone Sulfate
Drug Therapy, Combination
Estradiol
Female
Humans
Hydrocortisone
Hydroxyprogesterones
Menopause
Menstruation
Middle Aged

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
10874521Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.Drugs Aging2000https://conductscience.org/library/papers/10874521PubMed
8595151Aromatase inhibitors--where are we now?Br J Cancer1996https://conductscience.org/library/papers/8595151PubMed
8431370Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.Br J Cancer1993https://conductscience.org/library/papers/8431370PubMed
7949205First generation aromatase inhibitors--aminoglutethimide and testololactone.Breast Cancer Res Treat1994https://conductscience.org/library/papers/7949205PubMed
6684948Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6684948PubMed
6238616Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.Br J Cancer1984https://conductscience.org/library/papers/6238616PubMed
6221746Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6221746PubMed
3912013Could aminoglutethimide replace adrenalectomy?Breast Cancer Res Treat1985https://conductscience.org/library/papers/3912013PubMed
3778807Role of aminoglutethimide in male breast cancer.Br J Cancer1986https://conductscience.org/library/papers/3778807PubMed
3730249Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.Br J Cancer1986https://conductscience.org/library/papers/3730249PubMed
3436111Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings.Clin Pharmacokinet1987https://conductscience.org/library/papers/3436111PubMed
3358910The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.Br J Cancer1988https://conductscience.org/library/papers/3358910PubMed
3048976Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.Drugs1988https://conductscience.org/library/papers/3048976PubMed
2952154The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.Br J Cancer1987https://conductscience.org/library/papers/2952154PubMed
2933050A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.Br J Cancer1985https://conductscience.org/library/papers/2933050PubMed
2570093Endocrine therapy of metastatic breast cancer.J Endocrinol Invest1989https://conductscience.org/library/papers/2570093PubMed
2508735Use of luteinising hormone-releasing hormone agonist (leuprorelin) in advanced post-menopausal breast cancer: clinical and endocrine effects.Br J Cancer1989https://conductscience.org/library/papers/2508735PubMed
2145964The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.Br J Cancer1990https://conductscience.org/library/papers/2145964PubMed
2123133Comparison of the pharmacokinetics and pharmacodynamics of unformulated and formulated 4-hydroxyandrostenedione taken orally by healthy men.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2123133PubMed
1931611Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.Br J Cancer1991https://conductscience.org/library/papers/1931611PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6213633

GET https://conductscience.org/api/papers/v1/6213633/cited_by?page=2